Alikang Pharmaceutical Co., Ltd._Innovative drug research and development, Improved new drug research and development, Generic Drug Research and Development

Alikang Pharmaceutical Co., Ltd.

Focus on small molecule chemical drug research and development and industrialization of high-tech pharmaceutical enterprises

Company Culture

Professional focus team innovation

Corporate Vision

We are committed to becoming the world's leading R&D driven biomedical enterprise, and strive for human health





About Us

We are committed to becoming the world's leading R&D driven innovative technology enterprise

Founded in 2015 and headquartered in Haining, Zhejiang Province, Alikang Pharmaceutical Co., LTD., with a registered capital of 100 million yuan, is a high-tech pharmaceutical enterprise focusing on the research and development and industrialization of small molecule chemical drugs. It has three subsidiaries: Jiangsu Alikang Medical Technology Co., LTD., Zhejiang Alikang New Drug Research and Development Co., LTD., and Anhui Aliid Pharmaceutical Co., LTD.

The company is committed to becoming the world's leading R&D driven innovative technology enterprise, developing a class of innovative drugs and improved new drugs with fully independent intellectual property rights. The research pipeline includes tumor, autoimmune, cardiovascular and cerebrovascular, nervous system, etc. The company has established an innovative and competitive drug research and development system, with two R&D centers of 3500 square meters in Haining, Zhejiang Province, and 1,800 square meters in Nanjing, Jiangsu Province. ......

Intelligent drug design platform

The artificial intelligence method of deep learning is utilized to design novel drug molecules efficiently and predict their ADMET properties based on the concept of drug design based on structure and fragment and the library of small molecule compounds with excellent accessibility.

Systematic Biological Screening Platform

Pharmacological, pharmacological and toxicological evaluation of drug candidate molecules at the protein, cell and animal levels was conducted using advanced technologies of biochemistry, pharmacology and proteomics to provide real and accurate evaluation data for iterative optimization of innovative drug molecules and translational medicine.

Large-scale synthesis technology platform

There are 18 standardized synthesis laboratories and 4 pilot laboratories, capable of conducting various chemical reactions from mg to kg at the same time.

Drug Delivery Technology Platform

Independently carry out research on a variety of dosage forms such as slow-controlled release preparation, external preparation, oral solution, injection/lyophilized powder needle, etc., especially for the development and improvement of dosage forms of insoluble drugs and polycrystalline drugs.

Quality Analysis Research Platform

Equipped with Shimadsu/Agilent /Therm high performance liquid chromatography, Waters UPLC-QTof, AB SCIEX4500 QTRAP, gas chromatograph, laser particle size tester and other high-end instruments and equipment, can carry out systematic quality research on API, preparation and establish relevant quality standards according to ICH requirements.

Intelligent drug design platform

Systematic Biological Screening Platform

Large-scale synthesis technology platform

Drug Delivery Technology Platform

Quality Analysis Research Platform

Explore Alicang Pharmaceuticals